VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its financial results for the quarter ended March 31, 2025 (“Q1 2025”). The financial statements together with the related management’s discussion and analysis are available on the Company’s website and under the Company’s profile on SEDAR+ at www.sedarplus.ca. Highlights Generated revenue of US$1.2 million in Q1 2025.Produced 613 gold equivalent ounces(1) and sold 418 gol ...

Core Viewpoint - Hyperscale Data, Inc. has successfully paid 35 consecutive monthly cash dividends on its Series D Preferred Stock, reflecting its commitment to operational performance and shareholder value as it transitions into a pureplay AI data center platform [1][2]. Company Overview - Hyperscale Data operates through its subsidiary Sentinum, Inc., which manages a data center for mining digital assets and providing colocation and hosting services for AI ecosystems and other industries [3]. - The company also has another subsidiary, Ault Capital Group, Inc. (ACG), focused on acquiring undervalued businesses and disruptive technologies [3]. Future Plans - Hyperscale Data plans to divest ACG by December 31, 2025, after which it will focus solely on operating data centers for high-performance computing services, while potentially continuing Bitcoin mining [4]. - The divestiture will involve an exchange of Series F Preferred Stock for shares of ACG, allowing stockholders to become shareholders of ACG upon completion [5].

Anchorage Alaska, May 30, 2025 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce that preparations are now well underway for the upcoming field season at its over 500km2 flagship Estelle Project located in the Tintina Gold Belt in Alaska. A 15,000m drill program is set to commence shortly which will focus on key targets at RPM, Stibium, and Korbel. Highlights Helicopters, pad building crews, drillers, and geologists are now onsit ...

EDISON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of an offering of 18,750,000 shares of common stock at a price to the public of $4.00 per share (the “Offering”). The Offering is being made pursuant to the Securities Act of 1933, as amended (the “Securities Act”). The Company has granted the underwriters of the Offering, a 30-day option to purchase up to an additional 2,812,500 shares of common stock, at the publi ...

EDISON, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”) today announced the pricing of its offering of $225,000,000 aggregate principal amount of 6.75% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering ...

BEIJING, May 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company" or “TRX”), a China-based insurance broker, today announced plans to acquire 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China’s only cloud-based AI-driven hospital and health insurance risk management platform, in an all-share deal valued at US$150 million. This strategic move aims to unlock new growth opportunities in the health insurance segment. The Company and its wh ...

Highlights: Immuron on track to exceed A$7 million in Sales this financial yearUniformed Services University anticipates topline results of Travelan® clinical study in October 2025Immuron anticipates IMM-529 (Clostridiodes difficile infection) IND submission to the FDA in August 2025Launch plans underway for ProIBS® in AustraliaImmuron anticipates IMM-986 (Vancomycin-resistant enterococci) pre-clinical research results in August 2025 MELBOURNE, Australia, May 30, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (AS ...

Core Insights - Zymeworks Inc. announced the conditional approval of zanidatamab by the National Medical Products Administration (NMPA) in China for treating previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC), marking it as the first dual HER2-targeted bispecific antibody approved for this indication in China [1][10] - The approval is a significant advancement for patients with HER2-positive BTC, a group with high unmet medical needs and poor prognoses, and reflects the clinical potential of zanidatamab [2][4] - Zymeworks has received $61 million in upfront and milestone payments from its collaboration partner BeOne Medicines, with an additional $20 million milestone payment linked to the NMPA approval and potential for up to $144 million in further milestones [2][6] Company Overview - Zymeworks is a clinical-stage biotechnology company focused on developing multifunctional biotherapeutics for difficult-to-treat diseases, including cancer, inflammation, and autoimmune diseases [1][6] - The company utilizes its proprietary Azymetric™ technology to engineer and develop zanidatamab, which targets HER2 and induces various mechanisms leading to tumor growth inhibition [5][7] - Zymeworks has strategic partnerships with BeOne Medicines and Jazz Pharmaceuticals, granting exclusive rights for the development and commercialization of zanidatamab in different territories [7] Industry Context - Biliary tract cancers account for approximately 3% of all digestive system tumors, with a rising incidence rate globally, particularly in Asia [4] - Approximately 11%-25.2% of patients with BTC are HER2-positive, making HER2 a validated target for antitumor therapy [4] - Zanidatamab has also received FDA approval in the U.S. and is under regulatory review in the EU, indicating its potential as a best-in-class treatment for HER2-expressing cancers [3][7]

OKOTOKS, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation") is pleased to announce the closing of the acquisition of Cole Group Inc., Cole International Inc., Abco International Freight Inc. and all related entities (collectively the "Cole Group") effective June 1, 2025. Founded in the 1920s, the Cole Group is an industry leading full spectrum logistics services company specializing in customs brokerage, freight forwarding and trade ...

Core Insights - Aurora Mobile Limited has integrated the DeepSeek-R1-0528 AI model into its GPTBots.ai platform, enhancing its capabilities to compete with major players like OpenAI and Google [1][2][7] - The DeepSeek-R1-0528 model shows significant improvements in reasoning and coding performance, with AIME 2025 accuracy increasing from 70% to 87.5% and LiveCodeBench performance rising from 63.5% to 73.3% [2][3] - The model's open-source nature under the MIT License allows for commercial use and customization, aligning with the company's strategy to provide flexible AI solutions [5][6] Company Overview - Aurora Mobile, founded in 2011, is a leading provider of customer engagement and marketing technology services in China, focusing on stable messaging services and digital transformation solutions [11] - The company has developed various solutions, including Cloud Messaging and Cloud Marketing, to help enterprises achieve omnichannel customer reach [11] Product Features - The DeepSeek-R1-0528 model features a reduced hallucination rate and supports JSON output and function calling, facilitating seamless integration into business workflows [3][6] - A distilled version, DeepSeek-R1-0528-Qwen3-8B, is available for enterprises with limited compute resources, requiring only 16 GB of GPU memory while maintaining high performance [4] Market Implications - The integration of DeepSeek-R1-0528 enhances GPTBots.ai's ability to deliver advanced AI solutions across various industries, including finance, healthcare, education, and e-commerce [6][8] - The release highlights the growing potential of open-source AI models in enterprise applications, positioning GPTBots.ai to stay competitive in the evolving AI landscape [7]